Impact of GSTM1, GSTT1, GSTP1 polymorphism and environmental lead exposure on oxidative stress biomarkers

Scientific Research and Essays

Volumn 6, Issue 31, 2011, Pages 6540-6547

  Khansakorn, Nitchaphat ^a   Wongwit, Waranya ^a   Tharnpoophasiam, Prapin ^a   Hengprasith, Bunlue ^b   Suwannathon, Lerson ^a   Pethchpoung, Krittaya ^c   Yoovathaworn, Krongtong ^d   Chanprasertyothin, Suwannee ^e   Sura, Thunyachai ^e   Kaojarern, Sming ^e   Sritara, Piyamit ^e   Sirivarasai, Jintana ^e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Health Office   (Thailand)

^c KASETSART UNIVERSITY   (Thailand)

^d Mahidol University   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Glutathione; Glutathione Stransferase; Lead; Malondialdehyde; Polymorphisms

Indexed keywords

EID: 84055176429     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: 10.5897/SRE11.1519     Document Type: Article

References (25)

1. Ahamed M, Verma S, Kumar A, Siddiqui MK (2005). Environmental exposure to lead and its correlation with biochemical indices in children. Sci. Total. Environ., 346: 48-55.
2. Batariova A, Spevackova V, Benes B, Cejchanova M, Smíd J, Cerna M (2006). Blood and urine levels of Pb, Cd and Hg in the general population of the Czech Republic and proposed reference values. Int. J. Hyg. Environ. Health, 209: 359-366.
3. Beutler E, Duron O, Kelly BM (1963). Improved method for the determination of blood glutathione. J Lab. Clin. Med., 61: 882.
4. Bokara KK, Blaylock I, Denise SB, Bettaiya R, Rajanna S, Yallapragada PR (2009). Influence of lead acetate on glutathione and its related enzymes in different regions of rat brain. J. Appl. Toxicol., 29: 452-458.
5. Bolin NM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK, Cardozo-Pelaez F (2006). Exposure to lead and the development origin of oxidative DNA damage in the aging brain. FASEB. J., 20: 788-790.
6. Centers for Disease Control and Prevention (CDC) (2009). Adult blood lead epidemiology and surveillance--United States, 2005-2007. MMWR. Morb. Mortal. Wkly. Rep., 58(14): 365-369.
7. Falq G, Zeghnoun A, Pascal M, Vernay M, Strat YL, Garnier R, Olichon D, Philippe Bretin P, Castetbon K, Fréry N (2011). Blood lead levels in the adult population living in France the French Nutrition and Health Survey (ENNS 2006-2007). Environ. Int., 37: 565-571.
8. Galazyn-Sidorczuk M, Brzóska MM, Moniuszko-Jakoniuk J (2008). Estimation of Polish cigarettes contamination with cadmium and lead, and exposure to these metals via smoking. Environ. Monit. Assess., 137(1-3): 481-493.
9. Gundacker C, Wittmann KJ, Kukuckova M, Komarnicki G, Hikkel I, Gencik M (2009). Genetic background of lead and mercury metabolism in a group of medical students in Austria. Environ. Res., 109: 786-796.
10. Hayes JD, Strange RC (2000). Glutathione S-transferase polymorphisms and theirs biological consequences. Pharmacology, 61: 154-166.
11. Kasperczyk S, Kasperczyk J, Ostałowska A, Zalejska-Fiolka J, Wielkoszyński T, Swietochowska E, Birkner E (2009). The role of the antioxidant enzymes in erythrocytes in the development of arterial hypertension among humans exposed to lead. Biol. Trace. Elem. Res., 130(2): 95-106.
12. Khoschsorur GA, Winklhofer-Roob BM, Rabl H, Auer T, Peng Z, Schaur RJ (2000). Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia, 52: 181-184.
13. Kim JH, Hee Lee K, Yoo DH, Kanga D, Cho SH, Hong YC (2007). GSTM1 and TNF-α gene polymorphisms and relations between blood lead and inflammatory markers in a non-occupational population. Mutat. Res. 629: 32-39.
14. Kuo HW, Lai LH, Chou SY, Wu FY (2006). Association between blood lead level and blood pressure in aborigines and others in central Taiwan. Int. J. Occup. Environ. Health, 12(3): 222-227.
15. Kwon DD, Lee JW, Han DY, Seo IY, Park SC, Jeong HJ, Yang YS, Chae SC, Na KS, Mo KJ, Kim JJ, Rim JS (2011). Relationship between the Glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in Korean subjects. Korean. J. Urol., 52: 247-252.
16. Lee K, Leem, J, Park C, Hong Y (2007). GSTP1 Genetic polymorphisms and relations between environmental lead exposure and nitric oxide production. Epidemiology,18: S70.
17. Mak JC, Ho SP, Leung HC, Cheung AH, Law BK, So LK, Chan JW, Chau CH, Lam WK, Chan-Yeung M (2007). Relationship between glutathione S-transferase gene polymorphisms and enzyme activity in Hong Kong Chinese asthmatics. Clin. Exp. Allergy, 37: 1150-1157.
18. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E (2006). Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation, 114: 1388-1394.
19. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from nucleated cells. Nucleic. Acids. Res., 16(3): 1215.
20. Packer BR, Yeager M, Stats B, Welch R, Crenshaw A, Kiley M, Eckert A, Beerman M, Miller E, Bergen A, Rothman N, Strausberg R, Chanock SJ (2004). SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic. Acids. Res., 32: 528-532.
21. Patrick L (2006). Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern. Med. Rev., 11(2): 114-127.
22. Poovapanit A (1982). The determination of cadmium, lead and zinc in cigarettes and tobacco. Master dissertation, Chiang Mai University, Chiang Mai, Thailand.
23. Scinicariello F, Abadin HG, Edward Murray H (2011). Association of low-level blood lead and blood pressure in NHANES 1999-2006. Environ. Res., 111(8): 1249-1257.
24. Sirivarasai J, Kaojarern S, Wananukul W, Srisomerang P (2002). Non-occupational determinants of cadmium and lead in blood and urine among a general population in Thailand. Southeast. Asian. J. Trop. Med. Public. Health, 33: 180-187.
25. Subramanian KS, Meranger JC (1981). Rapid eletrothermal atomic absorption spectrometric method for cadmium and lead in human whole blood. Clin Chem., 27: 1866-1871.